Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Opioids Adcomm Postponed; Are Communications Freeze, Travel Ban To Blame?
Jan 27 2025
•
By
Sue Sutter
US FDA has postponed, without explanation, an advisory committee meeting on opioid postmarketing studies.
(Shutterstock)
More from US Advisory Committees
More from Product Reviews